News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Pembrolizumab followed by irreversible electroporation of a liver metastasis in Pancreatic Cancer patients
Nov 30, 2024, 16:08

Pembrolizumab followed by irreversible electroporation of a liver metastasis in Pancreatic Cancer patients

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared on X:

“Pembrolizumab followed by irreversible electroporation of a liver metastasis in pancreatic cancer patients: iScience

Authors: Rasmus Virenfeldt Flak, Emil Kofod-Olsen, Nikolaj Dich Sølvsten, Gintare Naujokaite, Ralf Agger, Mogens Tornby Stender, Signe Christensen, Susy Shim, Laurids Østergaard Poulsen, Sönke Detlefsen, Ole Thorlasius-Ussing, Morten Ladekar

Pembrolizumab followed by irreversible electroporation of a liver metastasis in Pancreatic Cancer patients

When you combine one ineffective therapy in pancreatic cancer (aPD1) with another (IRE), the cumulative result is still ineffective. Everyone progressed right through it.”

Pembrolizumab followed by irreversible electroporation of a liver metastasis in Pancreatic Cancer patients

Anirban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.

Anirban Maitra cancer Emil Kofod-Olsen Gintare Naujokaite Laurids Østergaard Poulsen Liver metastasis Mogens Tornby Stender Morten Ladekar Nikolaj Dich Sølvsten Ole Thorlasius-Ussing OncoDaily Oncology Pancreatic Cancer Ralf Agger Rasmus Virenfeldt Flak Signe Christensen Sönke Detlefsen Susy Shim
Special Coverage
Blog
Feb 21, 2025, 12:29
The launch of the Access Cancer Treatment for Children initiative - Childhood Cancer International
Blog
Feb 21, 2025, 11:52
Zainab Shinkafi-Bagudu: Exploring collaborations in cancer care with the Indian High Commission in Abuja
Blog
Feb 21, 2025, 11:51
Integrative medicine for cancer-related pain and anxiety/depression - Society for Integrative Oncology
Insight
Feb 21, 2025, 11:40
Zoë Mullan: The launch of our much-anticipated Commission on medical oxygen security
Science
Feb 21, 2025, 11:36
Myeloma Paper of the Day, February 21st, suggested by Robert Orlowski
Dialogues
Feb 21, 2025, 11:29
HPV Self-Collection for Cervical Cancer: Dr. Kay's Insights
Science
Feb 21, 2025, 11:03
George Vlachogiannis: A growing CRC burden among younger individuals in high socio-demographic index regions
Blog
Feb 21, 2025, 11:02
Divya Sachdev: Building a future where every child, no matter where they live, has a fair chance at survival
Blog
Feb 21, 2025, 10:55
Giuseppe Curigliano: Mourning the untimely passing of Giovanni Scambia - a visionary leader in European gynecologic oncology
Blog
Feb 21, 2025, 10:45
Saurabh Zanwar: Clonal plasma cell proportion in the S-phase in multiple myeloma
Blog
Feb 21, 2025, 10:37
Cihangir Akyol: A comprehensive review on colorectal ESD outcomes by Lumir Kunovsky
Celebrities
Feb 21, 2025, 10:28
In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer